ALDH1A2 suppresses the proliferation and migration of epithelial ovarian cancer cells by downregulating STAT3, and enhanced ALDH1A2-related signalling may provide new opportunities for therapeutic intervention in ovarian cancer.149. Here, STAT3 is linked to ovarian carcinoma.